Advanced Search
QIU Zhi-yun, WANG Hui-lin, XIA Mu-chao, et al. Progress of cardiovascular protective effects of dexmedetomidine[J]. Chin J Clin Med, 2022, 29(1): 111-117. DOI: 10.12025/j.issn.1008-6358.2022.20210890
Citation: QIU Zhi-yun, WANG Hui-lin, XIA Mu-chao, et al. Progress of cardiovascular protective effects of dexmedetomidine[J]. Chin J Clin Med, 2022, 29(1): 111-117. DOI: 10.12025/j.issn.1008-6358.2022.20210890

Progress of cardiovascular protective effects of dexmedetomidine

  • Dexmedetomidine, an α-2 adrenoreceptor (α2-AR) agonist, is a commonly used drug at present, which can protect the cardiovascular system during the perioperative period. The possible mechanisms include decreasing the hemodynamic change, inhibiting cardiomyocyte apoptosis, reducing myocardial inflammatory response, improving microcirculation dysfunction after myocardial ischemia-reperfusion, protecting mitochondrial structure and function, and anti-arrhythmia. This review focuses on the mechanisms of protection, clinical applications, and adverse reactions of dexmedetomidine in the cardiovascular system.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return